Also known as: Jakafi; Jakavi; INCB018424
Ruxolitinib is a high-purity Active Pharmaceutical Ingredient (API) classified under JAK1/JAK2 Inhibitor / Antineoplastic Agent. Mediocon Inc manufactures GMP-compliant Ruxolitinib at its state-of-the-art facility in Aurangabad, Maharashtra, India, supplying pharmaceutical companies worldwide with consistent quality and full regulatory documentation.
| Parameter | Specification |
|---|---|
| CAS Number | 941678-49-5 |
| Molecular Formula | C₁₇H₁₈N₆ |
| Molecular Weight | 306.37 g/mol |
| Grade | IP / BP / EP / USP |
| Category | JAK1/JAK2 Inhibitor / Antineoplastic Agent |
| Assay | NLT 98.0% |
| Loss on Drying | NMT 0.5% |
| Heavy Metals | NMT 20 ppm |
| Residue on Ignition | NMT 0.1% |
| Microbial Limits | Complies with pharmacopoeia |
| Identification | IR, HPLC Compliant |
| Batch No | RUX/24032026 |
| Mfg Date | MAR 2026 |
| Exp Date | FEB 2031 |
| Packing | 25 kg HDPE drums / as per requirement |